GE Healthcare wins FDA clearance for Alzheimer’s imaging software
The clearance adds a Centiloid scale tool to GE Healthcare’s Mim software to help clinicians determine the density of amyloid ...
AI Is Redefining The Hepatitis B And C Diagnostics Market, Set To Grow By...
Report with market evolution powered by AI- The global hepatitis b and c diagnostics market size is estimated to grow by USD ...
Hosted on MSN2d
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
GE HealthCare Technologies’ GEHC MIM Software recently announced the receipt of FDA clearance for performing Centiloid ...
Yahoo Finance2d
Europe Molecular Diagnostics Market Size & Share to Surpass USD 17.3 billion by 2034 | Analysis by Transparency Market Research, Inc.
In Europe's molecular diagnostics landscape, key players like Roche Diagnostics, Abbott Laboratories, and Siemens ...
EurekAlert!3d
New Alzheimer’s studies reveal disease biology, risk for progression, and the potential for a novel blood test
Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...